{ "items": [ "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Survival, dependency and health-related quality of life in patients with ruptured intracranial aneurysm: ten-year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT)\n

\n \n \n \n \n\n \n \n \n

HUA X. et al, (2020), Neurosurgery

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Patient-reported outcome measures (PROMs): can they be used to guide patient-centered care and optimize outcomes in total knee replacement?\n

\n \n \n \n \n\n \n \n \n

Tew M. et al, (2020), Qual Life Res

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Effects of Allopurinol on the Progression of Chronic Kidney Disease.\n

\n \n \n \n \n\n \n \n \n

Badve SV. et al, (2020), N Engl J Med, 382, 2504 - 2513

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes.\n

\n \n \n \n \n\n \n \n \n

Tran-Duy A. et al, (2020), Diabetes Care

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Group Testing for SARS-CoV-2: Forward to the Past?\n

\n \n \n \n \n\n \n \n \n

Pouwels KB. et al, (2020), Pharmacoecon Open, 4, 207 - 210

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n CANCER RISK AND RESOURCE UTILIZATION FOR 5 COMMON CANCERS IN A MATCHED CHINESE DIABETES POPULATION OF 331,000 PATIENTS\n

\n \n \n \n \n\n \n \n \n

Wu N. et al, (2020), VALUE IN HEALTH, 23, S58 - S58

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Group Testing for SARS-CoV-2: Forward to the Past?\n

\n \n \n \n \n\n \n \n \n

Pouwels KB. et al, (2020), PharmacoEconomics - Open

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Attitudes of patients and surgeons towards sham surgery trials: a protocol for a scoping review of attributes to inform a discrete choice experiment.\n

\n \n \n \n \n\n \n \n \n

Wall L. et al, (2020), BMJ Open, 10

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Accurately reflecting uncertainty when using patient-level simulation models to extrapolate clinical trial data\n

\n \n \n \n \n\n \n \n \n

DAKIN H. et al, (2020), Medical Decision Making

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Registered Reports: Time to Radically Rethink Peer Review in Health Economics\n

\n \n \n \n \n\n \n \n \n

CLARKE P. et al, (2020), PharmacoEconomics - Open

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials.\n

\n \n \n \n \n\n \n \n \n

Hua X. et al, (2020), Diabet Med

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Co-morbidities and sex differences in long-term quality-of-life outcomes among patients with and without diabetes after total knee replacement: Five-year data from registry study\n

\n \n \n \n \n\n \n \n \n

Tew M. et al, (2020), Journal of Clinical Medicine, 9

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Defining and measuring health poverty\n

\n \n \n \n \n\n \n \n \n

Clarke P. and Erreygers G., (2020), Social Science and Medicine, 244

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Exploring the Impact of Quality of Life on Survival: A Case Study in Total Knee Replacement Surgery\n

\n \n \n \n \n\n \n \n \n

Tew M. et al, (2020), Medical Decision Making

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Primary Prevention of Cardiovascular Disease in Minority Indigenous Populations: A Systematic Review\n

\n \n \n \n \n\n \n \n \n

Merone L. et al, (2020), Heart Lung and Circulation

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The acceptability of using a lottery to allocate research funding: a survey of applicants.\n

\n \n \n \n \n\n \n \n \n

Liu M. et al, (2020), Res Integr Peer Rev, 5

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The Surgeon's Role in the Opioid Crisis: A Narrative Review and Call to Action.\n

\n \n \n \n \n\n \n \n \n

Shadbolt C. et al, (2020), Front Surg, 7

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial\n

\n \n \n \n \n\n \n \n \n

Furler J. et al, (2020), The Lancet Diabetes and Endocrinology, 8, 17 - 26

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.\n

\n \n \n \n \n\n \n \n \n

Kent S. et al, (2019), PharmacoEconomics

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.\n

\n \n \n \n \n\n \n \n \n

Tew M. et al, (2019), Pharmacoeconomics, 37, 931 - 941

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n" ], "more": "\n\n \n \n Load More\n \n \n\n", "msg": "" }